Benjamin L. Ebert, President and CEO at Dana-Farber Cancer Institute, shared a post on LinkedIn:
“As Dana-Farber Cancer Institute continues to grow, we are excited to have signed a letter of intent to open a new ambulatory building located at 60 Guest St. in Brighton, Mass., at Boston Landing.
Pending regulatory approval, we aim to open the new practice in summer 2029. The beautiful space will include exam rooms, infusion, pharmacy, radiology, lab services and clinical trials together in one location to deliver multidisciplinary care.
With increasing cancer incidence, more patients are turning to us for their cancer care. As always, their needs remain at the center of everything we do. This additional state-of-the art ambulatory practice will enable us to provide exceptional care to more patients who are counting on us.”
Other articles featuring Benjamin L. Ebert on OncoDaily.